All Antibody articles – Page 2

News
Doctors turn to experimental Ebola treatments

2014-08-20T00:00:00Z

Drugs and vaccines untested in humans are being trialled on Ebola patients
Business
Merck & Co doubles up on Ablynx research deal

2014-02-04T00:00:00Z

Cancer nanobody R&D partnership could be worth €1.7 billion
Business
Sanofi suffers multiple sclerosis setback

2014-01-03T00:00:00Z

US drug agency will not approve alemtuzumab
Business
Celgene buys into anticancer antibodies

2013-12-04T00:00:00Z

Partners with OncoMed in a deal worth up to $3.3bn
Business
Roche backs biologics boom

2013-10-15T00:00:00Z

Swiss firm to invest heavily in manufacturing for complex biological drugs
Business
Nanobody inflammation drug attracts Abbvie

2013-09-25T00:00:00Z

$840m licensing deal shows support for antibody fragments
Business
First biosimilar antibody drugs approved in Europe

2013-09-11T00:00:00Z

European commission gives final approval to generic infliximab copies
Business
Biosimilar drugs step up complexity

2013-07-02T00:00:00Z

First generic monoclonal antibodies recommended for approval in Europe
News
Regeneron expands, creating 400 new jobs

2013-04-04T00:00:00Z

US biotech firm announces second expansion in six months
Business
Merck & Co $460m ion channel deal

2012-10-02T00:00:00Z

Deal with Ablynx relates to antibody fragments
Business
Bapineuzunab dropped

2012-08-09T00:00:00Z

Development for the Alzheimer’s treatment stopped after clinical tests
Business
Three pronged approach puts brakes on US breast cancer

2012-06-12T00:00:00Z

US approval for anti-HER2 therapy Perjeta (pertuzumab) against breast cancer

Previous Page
Page1
Page2
Next Page